Guest Contributor


Organizations:
Biofund Management, Genizon Biosciences, HBM Bioventures, and MVI Finance

Genizon secures $12.4 million in new financing

Guest Contributor
April 14, 2006

Montreal’s Genizon Biosciences has closed $12.4 million in first tranche secured convertible debenture financing to increase its inventory of GeneMaps and disease drug targets. The syndicated financing includes HBM Bioventures, Biofund Management, and MVI Finance, as well as Genizon management, board members, employees and Illumina Inc


Other News

Industry/S&T committee reverts to original focus

IBM and UHN create new research centre at MaRS

CRA clarifies eligibility of outsourcing under SR&ED

Precarn provides $4.9M for six intelligent ICT projects






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.